Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
CATB | Exit | Catabasis Pharmaceuticals Inc. | $0 | – | -2,008,192 | -100.0% | -0.38% | – |
EPIX | Exit | ESSA Pharma Inc. | $0 | – | -1,668,560 | -100.0% | -1.18% | – |
VBIV | Exit | VBI Vaccines Inc. | $0 | – | -2,691,042 | -100.0% | -1.53% | – |
HAIR | Exit | Restoration Robotics Inc. | $0 | – | -3,569,986 | -100.0% | -2.43% | – |
ETTX | Exit | Entasis Therapeutics Holdings Inc | $0 | – | -1,623,405 | -100.0% | -4.15% | – |
GRTS | Exit | Gritstone Oncology Inc | $0 | – | -2,567,445 | -100.0% | -8.59% | – |
FTSV | Exit | Forty Seven Inc | $0 | – | -3,816,951 | -100.0% | -13.38% | – |
SIEN | Exit | Sientra Inc. | $0 | – | -2,730,765 | -100.0% | -15.33% | – |
NSTG | Exit | Nanostring Technologies Inc. | $0 | – | -4,036,025 | -100.0% | -16.91% | – |
AVRO | Exit | AvroBio Inc. | $0 | – | -2,962,325 | -100.0% | -36.11% | – |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Nanostring Technologies Inc. | 20 | Q3 2018 | 60.2% |
Sientra Inc. | 16 | Q3 2018 | 38.2% |
Oxford Immunotex Global PLC | 14 | Q1 2017 | 17.4% |
Catabasis Pharmaceuticals Inc. | 14 | Q3 2018 | 15.3% |
VBI Vaccines Inc. | 10 | Q3 2018 | 11.4% |
TetraLogic Pharmaceuticals Corporation | 9 | Q4 2015 | 12.5% |
ESSA Pharma Inc. | 9 | Q1 2018 | 6.5% |
Aerie Pharmaceuticals Inc. | 7 | Q4 2015 | 30.5% |
VBI Vaccines Inc. | 7 | Q1 2016 | 9.1% |
Ophthotech Corp | 6 | Q1 2015 | 31.5% |
View Clarus Ventures, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
N-PX | 2024-08-30 |
13F-NT | 2024-08-14 |
13F-NT | 2024-05-15 |
13F-NT | 2024-02-14 |
13F-NT | 2023-11-14 |
13F-NT | 2023-08-14 |
13F-NT | 2023-05-15 |
13F-NT | 2023-02-14 |
13F-NT | 2022-11-14 |
13F-NT | 2022-08-15 |
View Clarus Ventures, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.